New research from the University of Cincinnati (UC) points to the naturally produced protein apolipoprotein A-IV (apoA-IV) as a potential target for a new diabetes therapeutic.
Read more
Study identifies apolipoprotein as target for diabetes drug
Posted in Drugs Medical Research